Celadon Pharmaceuticals PLC Net Asset Momentum
Celadon Pharmaceuticals PLC net asset momentum. Celadon Pharmaceuticals PLC (CEL) recorded a net asset momentum of -54.8% as of December 2023, with net assets of GBX3.18 Million GBX. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Celadon Pharmaceuticals PLC capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Celadon Pharmaceuticals PLC (2019–2023)
Net asset momentum of Celadon Pharmaceuticals PLC from 2019 to 2023. This chart tracks Celadon Pharmaceuticals PLC's year-over-year net asset growth across 5 annual reporting periods from 2019 to 2023. The most recent momentum reading is -54.8%, with net assets of GBX3.18 Million GBX as of December 2023. See CEL total equity for net asset value and shareholders' equity analysis.
Celadon Pharmaceuticals PLC Net Asset Momentum by Year (2019–2023)
Celadon Pharmaceuticals PLC net asset momentum by year from 2019 to 2023. The table below shows the complete annual net asset history for Celadon Pharmaceuticals PLC from 2019 to 2023, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see how much is Celadon Pharmaceuticals PLC worth.
| Year | Net Assets (GBX) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2023 | GBX3.18 Million | GBX9.22 Million | GBX6.04 Million | ▼ -54.8% |
| 2022 | GBX7.04 Million | GBX13.25 Million | GBX6.21 Million | ▲ +9.8% |
| 2021 | GBX6.41 Million | GBX6.61 Million | GBX197.23K | ▲ +6373.2% |
| 2020 | GBX99.03K | GBX3.85 Million | GBX3.75 Million | ▲ +187.3% |
| 2019 | GBX-113.47K | GBX2.49 Million | GBX2.60 Million | — |